NanoAhtero
BL-Nanobiomed

BL Nanobiomed

Posted On: 20 Οκτωβρίου 2023

NanoAhtero

logo

Development and Preclinical Validation of biofunctionalized Nanoparticles for targeted delivery of antithrombotic and antioxidant factors to treat Atherosclerosis